New Funding for Cameroon Will Be Used for Health Products

[GFO]The $20.4 million in interim applicant funding approved for Cameroon (first announced in this GFO article) will be used exclusively to procure antiretrovirals (ARVs), related health products and medicines to treat opportunistic infections. The money will be added to an existing HIV grant, CMR-011-G11-H, for which the principal recipient is the Ministry of Public Health (MPH), to be used over the remaining ten months of Phase 1 of that grant.

Related posts